Retatrutide and Dizziness: Blood Sugar and Hydration

Dizziness during retatrutide treatment is typically caused by two highly treatable factors: dehydration from reduced fluid intake and blood sugar normalization (Jastreboff et al., NEJM 2023). When patients eat and drink less due to appetite suppression, both fluid volume and blood glucose can drop enough to cause lightheadedness. Understanding these causes makes dizziness preventable in most cases.

Common Causes

• Dehydration: Reduced appetite leads to reduced fluid intake. Even mild dehydration (2-3% body weight) causes dizziness.
• Blood sugar normalization: If your body is accustomed to high blood sugar, the normalization caused by retatrutide can feel like hypoglycemia.
• Orthostatic hypotension: Blood pressure drop when standing, exacerbated by dehydration and weight loss.
• Caloric restriction: Very low caloric intake can cause lightheadedness.
• Electrolyte imbalances: Sodium, potassium, or magnesium depletion from reduced food intake.

Prevention Strategies

• Drink 64-80 oz water daily: Set reminders — do not rely on thirst alone
• Stand slowly: Rise from sitting or lying gradually over 10-15 seconds
• Eat regular small meals: Do not skip meals even if appetite is low
• Electrolyte supplementation: Sodium, potassium, magnesium through food or supplements
• Monitor blood sugar: If diabetic, check glucose when dizziness occurs
• Adjust blood pressure medications: Weight loss may reduce blood pressure, requiring medication dose adjustments

When Dizziness Is Serious

• Fainting or near-fainting episodes
• Dizziness with chest pain or palpitations
• Persistent dizziness despite adequate hydration
• Dizziness with vision changes or slurred speech (seek emergency care)
• Blood sugar below 70 mg/dL (treat immediately with glucose)

Treatment Support

Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with medical monitoring to prevent and manage dizziness. Get started with Trimi.

Frequently Asked Questions

Is dizziness common on retatrutide?

Dizziness is reported by some patients, primarily during dose escalation. It is almost always related to dehydration or blood sugar changes rather than a direct drug effect.

Can retatrutide cause low blood sugar?

Retatrutide (like other GLP-1 medications) has low risk of true hypoglycemia when used alone. Risk increases when combined with insulin or sulfonylureas. The glucose-dependent mechanism means it primarily lowers elevated blood sugar, not normal levels.

Should I check my blood pressure on retatrutide?

Yes, especially if you take blood pressure medication. Significant weight loss often lowers blood pressure, and your medications may need to be reduced to prevent dizziness from low blood pressure.

Will the dizziness go away?

Usually, yes. Once hydration habits are established and the body adjusts to new blood sugar levels, dizziness resolves. Persistent dizziness warrants medical evaluation.